Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04410731 · ClinicalTrials.gov registry record · Phase 1
Allogeneic BM-MSCs in Patients with Lumbar Facet Arthropathy
A Phase 1 study of Facet-Mediated Low Back Pain, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT04410731: Completed Phase 1 study of Facet-Mediated Low Back Pain, sponsored by Mayo Clinic.
NCT04410731 is a Phase 1 study of Facet-Mediated Low Back Pain that has completed, run by Mayo Clinic. The registered enrollment target is 10 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04410731, a Phase 1 study of Facet-Mediated Low Back Pain, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
Researchers are conducting this study to learn more about the side effects of bone marrow-derived stem cells when injected into the facet joints for the treatment of painful lumbar facet joint arthropathies.
Primary Outcome
Clinical examination face-to-face during follow-up visits
Conditions Studied
Interventions
- DRUG Single bilateral intra-articular injection of allogeneic BM-MSCs for lumbar facet joint arthropathy
Study Locations (1)
Florida
- Mayo Clinic in Florida - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2020-04-28 |
| Est. Completion | 2024-03-15 |
| Phase | Phase 1 |
What the finished NCT04410731 record still lists
NCT04410731 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Facet-Mediated Low Back Pain appearing as the primary indexed condition, and to 1 intervention - of which Single bilateral intra-articular injection of allogeneic BM-MSCs for lumbar facet joint arthropathy is the first listed.
NCT04410731 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT04410731 about?
NCT04410731 is a clinical study titled "Allogeneic BM-MSCs in Patients with Lumbar Facet Arthropathy". Researchers are conducting this study to learn more about the side effects of bone marrow-derived stem cells when injected into the facet joints for the treatment of painful lumbar facet joint arthropathies.
What is the current status of trial NCT04410731?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2020-04-28. Estimated completion is 2024-03-15.
What conditions does trial NCT04410731 study?
This clinical trial studies the following conditions: Facet-Mediated Low Back Pain.
What interventions are being tested in trial NCT04410731?
The interventions under investigation include: Single bilateral intra-articular injection of allogeneic BM-MSCs for lumbar facet joint arthropathy (DRUG).
Who is sponsoring clinical trial NCT04410731?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04410731 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Facet-Mediated Low Back Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04410731's enrollment target sits among peer trials
10 1913th of 2000 higher than 46 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI